Pressure BioSciences, Inc. Announces Commercial Launch of its Unique Biopharmaceuticals Contract Services Business
January 07, 2019 Proprietary Technology Platform Offers Improved Manufacturing for Protein Therapeutic Candidates and Positions PBI to Service the $250 Billion Global Biopharmaceuticals Market SOUTH EASTON, MA / ACCESSWIRE / January 7, 2019 / Pressure BioSciences, Inc. (OTCQB: PBIO) (“PBI” and the “Company”), a leader in the development and sale of enabling high pressure-based instruments, consumables,... Read more